0,1,2,3,4,5
Table 6.3.9:  Treatment-related toxicity and BCR-free probability in selected salvage brachytherapy,,,,,
Study,Study design,,"n and BT type Median FU 
(mo)",Treatment toxicity,BCR-free probability
"Lopez, et al. 
2019 [1090]","multi-centre 
retrospective","75 HDR 
44 LDR",52,23.5% late G3+ GU,"5 yr 71%  
(95% CI: 65.9-75.9%)"
"Crook, et al. 
2019 [1091]","multi-centre 
prospective",100 LDR,54,"14% late G3 
combined GI/GU",n.r.
"Smith, et al. 
2020 [1092]","single-centre 
retrospective",108 LDR,76,"15.7%/2.8% late G3 
GU/GI","5 yr. 63.1%
10 yr. 52%"
"Lyczek, et al. 
2009 [1093]","single-centre 
retrospective",115 HDR,n.r.,"12.2%/0.9%
late G3+ GU/GI",60% at 40 mo.
